Retour
Prix IO Biotech Inc (IOBT)
Graphique du cours de l'action IOBT
IOBT Dividendes
IO Biotech Inc
$0.5
-2.69%
$-0.01
À la fermeture : Jan 16, 16:00:00 GMT-5
$0.51
1.57%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$0.516
Prix d'ouverture
$0.516
Plage de la journée
$0.5 - $0.516
Plage de 52 semaines
$0.323 - $2.79
Volume
436.1K
Volume moyen
2.2M
BPA (TTM)
-1.34
Rendement en dividend
--
Capitalisation boursière
$36.6M
Qu’est-ce que IOBT ?
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
